Enlaza Therapeutics Revenue and Competitors

Location

$161M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Enlaza Therapeutics's estimated annual revenue is currently $5.1M per year.(i)
  • Enlaza Therapeutics's estimated revenue per employee is $77,500
  • Enlaza Therapeutics's total funding is $161M.

Employee Data

  • Enlaza Therapeutics has 66 Employees.(i)
  • Enlaza Therapeutics grew their employee count by 32% last year.

Enlaza Therapeutics's People

NameTitleEmail/Phone
1
Co-Founder and CEOReveal Email/Phone
2
Co-Founder, President and CBOReveal Email/Phone
3
Chief Scientific OfficerReveal Email/Phone
4
Head Lab OperationsReveal Email/Phone
5
VP, Head Human ResourcesReveal Email/Phone
6
SVP, CMC Product DevelopmentReveal Email/Phone
7
VP Pharmacology and Translational ResearchReveal Email/Phone
8
VP Pharmacology and Translational ResearchReveal Email/Phone
9
VP Business DevelopmentReveal Email/Phone
10
VP, ChemistryReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is Enlaza Therapeutics?

Enlaza Therapeutics is pioneering the field of covalent biologics.These novel classes of protein therapeutics deliver more efficacious and safer treatments for patients. The company’s proprietary War-LockTM platform leverages leading synthetic biology technology for site-specific covalent coupling driven by drug binding. Enlaza is building a pipeline of first-in-class covalent biologics.

keywords:N/A

$161M

Total Funding

66

Number of Employees

$5.1M

Revenue (est)

32%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.6M66-11%N/A
#2
$5.1M6610%$376.5M
#3
$16M6612%N/A
#4
$3.5M663%N/A
#5
$10.2M66-20%N/A